Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01766011 · ClinicalTrials.gov registry record · Phase 2
Evaluation of a Standard Preterm Infant Formula Fed to Preterm Infants in the Hospital
A Phase 2 study, sponsored by Abbott Nutrition.
- Completed
- Registry status
- Phase 2
- Development phase
- 28
- Enrollment target
NCT01766011: Completed Phase 2 study, sponsored by Abbott Nutrition.
NCT01766011 is a Phase 2 study that has completed, run by Abbott Nutrition. The registered enrollment target is 28 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01766011, a Phase 2 study, has completed, sponsored by Abbott Nutrition.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 28 participants
- Enrollment target
Study Summary
The purpose of this study is to assess overall growth of preterm infants fed a reformulated preterm infant formula during hospitalization. All study products meet levels of nutrients for the infant population as specified in the Infant Formula Act and all subsequent amendments.
Primary Outcome
weight gain per day (g/kg/d)
Interventions
- OTHER study pre-term formula
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2012-11 |
| Est. Completion | 2013-10 |
| Phase | Phase 2 |
What the finished NCT01766011 record still lists
NCT01766011 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 1 intervention - of which study pre-term formula is the first listed.
NCT01766011 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01766011 about?
NCT01766011 is a clinical study titled "Evaluation of a Standard Preterm Infant Formula Fed to Preterm Infants in the Hospital". The purpose of this study is to assess overall growth of preterm infants fed a reformulated preterm infant formula during hospitalization. All study products meet levels of nutrients for the infant population as specified in the Infant Formula Act and all subsequent amendments.
What is the current status of trial NCT01766011?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 28 participants. The study started on 2012-11. Estimated completion is 2013-10.
What interventions are being tested in trial NCT01766011?
The interventions under investigation include: study pre-term formula (OTHER).
Who is sponsoring clinical trial NCT01766011?
This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01766011's enrollment target sits among peer trials
28 1677th of 2000 higher than 304 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia